In Patients With Crohn's Disease, Timing of Switching From Infliximab Maintenance Therapy to Adalimumab Affects Patients' Prognosis

被引：0
|
作者：
Takeuchi, Ken
Yamada, Akihiro
Suzuki, Yasuo
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1127
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [1] In patients with Crohn's disease, timing of switching from infliximab to adalimumab affects prognosis
    Takeuchi, K.
    Yamada, A.
    Suzuki, Y.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S249 - S249
  • [2] Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. -C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    De Vos, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S274 - S274
  • [3] Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    Vander Cruyssen, B.
    Gils, A.
    De Vos, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (01) : 15 - 21
  • [4] Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab
    Shafran, I
    Burgunder, P.
    Fakih, A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S44
  • [5] Clinical Impact of Evaluating Suitable Timing for Switching From Infliximab to Adalimumab According to Precise Endoscopic Monitoring in Patients With Crohn's Disease
    Kamata, Noriko
    Watanabe, Kenji
    Morimoto, Kenichi
    Noguchi, Atsushi
    Miyazaki, Takako
    Sogawa, Mitsue
    Yamagami, Hirokazu
    Nagami, Yasuaki
    Sugimori, Satoshi
    Tanigawa, Tetsuya
    Shiba, Masatsugu
    Tominaga, Kazunari
    Watanabe, Toshio
    Fujiwara, Yasuhiro
    Arakawa, Tetsuo
    GASTROENTEROLOGY, 2014, 146 (05) : S249 - S249
  • [6] Elective Switching from Infliximab to Adalimumab in Stable Crohn's Disease
    Hoentjen, Frank
    Haarhuis, Bertram J. T.
    Drenth, Joost P. H.
    de Jong, Dirk J.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 761 - 766
  • [7] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
  • [8] Adalimumab maintenance therapy improves quality of life in patients with Crohn's disease
    Nature Reviews Gastroenterology & Hepatology, 2009, 6 (3) : 129 - 129
  • [9] Comparison of Infliximab and Infliximab/Azathioprine for Maintenance Therapy in Korean Patients with Luminal Crohn's Disease
    Won, Hyun Sun
    Park, Dong Il
    Chon, Chang Uk
    Seok, Hyo Sun
    Kim, Tae Wan
    Heo, Woon Je
    Lee, Chang Kyun
    Eun, Chang Soo
    Han, Dong Soo
    Lee, Suck-Ho
    INTESTINAL RESEARCH, 2011, 9 (03) : 189 - 195
  • [10] Clinical usefulness and problems of maintenance therapy with Infliximab in patients with Crohn's Disease
    Yokoyama, K.
    Kobayashi, K.
    Mukae, M.
    Yamagata, M.
    Fukushima, H.
    Sada, M.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S45 - S45
12345